Cargando…
The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships
Cholera, a diarrheal disease primarily affecting vulnerable populations in developing countries, is estimated to cause disease in more than 2.5 million people and kill almost 100,000 annually. An oral cholera vaccine (OCV) has been available globally since 2001; the demand for this vaccine from affe...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203809/ https://www.ncbi.nlm.nih.gov/pubmed/30314912 http://dx.doi.org/10.1016/j.vaccine.2018.09.026 |